Ablative Technologies for Urologic Cancers

Urologic Clinics of North America

Volumn 36, Issue 2, 2009, Pages 163-178

  Vricella, Gino J ^a   Ponsky, Lee E ^a   Cadeddu, Jeffrey A ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Ablation; Cryotherapy; Percutaneous; Prostate cancer; Radiofrequency; Radiosurgery; Renal tumors

Indexed keywords

CRYOABLATION; HUMAN; KIDNEY CANCER; LAPAROSCOPY; MICROWAVE ABLATION; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; RADIOFREQUENCY ABLATION; RADIOSURGERY; REVIEW; STEREOTACTIC PROCEDURE; ULTRASOUND; URINARY TRACT CANCER; UROLOGIC SURGERY;

ABLATION TECHNIQUES; CATHETER ABLATION; HUMANS; KIDNEY NEOPLASMS; LAPAROSCOPY; MALE; PROSTATIC NEOPLASMS; RADIOSURGERY;

EID: 65249136475     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ucl.2009.02.003     Document Type: Review

References (96)

1. American Cancer Society. Facts and figures, 2007.
2. Jayson M., and Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 51 (1998) 203-205
3. Chawla S.N., Crispen P.L., Hanlon A.L., et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175 (2006) 425-431
4. Van Poppel H. Conservative versus radical surgery for renal cell carcinoma. BJU Int 94 (2004) 766-768
5. Uchida M., Imaide Y., Sugimoto K., et al. Percutaneous cryosurgery for renal tumors. Br J Urol 75 (1995) 132-136 [discussion: 136-7]
6. Chosy S.G., Nakada S.Y., Lee F.T., et al. Monitoring renal cryosurgery: predictors of tissue necrosis in swine. J Urol 159 (1998) 1370-1374
7. Hoffman N.E., and Bischof J.C. The cryobiology of cryosurgical injury. Urology 60 (Suppl 2A) (2002) 40-49
8. Gill I.S., and Novick A.C. Renal cryosurgery. Urology 54 (1999) 215-219
9. Baust J.G., and Gage A.A. The molecular basis of cryosurgery. BJU Int 95 (2005) 1187-1191
10. Hedican S.P., Wilkinson E.R., Lee F.T., et al. Cryoablation of advanced renal cancer has a survival advantage in a murine model compared to nephrectomy. J Urol 171 4 Suppl (2004) [abstract No. 778]
11. Larson T.R., Robertson D.W., Corica A., et al. In vivo interstitial temperature mapping of the human prostate during cryosurgery with correlation to histopathology outcome. Urology 55 (2000) 547-552
12. Campbell S.C., Krishnamurthi V., Chow G., et al. Renal cryosurgery: experimental evaluation of treatment parameters. Urology 52 (1998) 29-33
13. Woolley M.L., Schulsinger D.A., Durand D.B., et al. Effect of freezing parameters (freeze cycle and thaw process) on tissue destruction following renal cryoablation. J Endourol 16 (2002) 519-522
14. Sung G.T., Gill I.S., Hsu T.H., et al. Effect of intentional cryoinjury to the renal collecting system. J Urol 170 (2003) 619-622
15. Janzen N.K., Perry K.T., Han K.R., et al. The effects of intentional cryoablation and radio frequency ablation of renal tissue involving the collecting system in a porcine model. J Urol 173 (2005) 1368-1374
16. Gill I.S., Novick A.G., Meraney A.M., et al. Laparoscopic renal cryoablation in 32 patients. Urology 56 (2000) 748-753
17. Davol P.E., Fulmer B.R., and Rukstalis D.B. Long-term results of cryoablation for renal cancer and complex renal masses. Urology 68 (2006) 2-6
18. Schwartz B.F., Rewcastle J.C., Powell T., et al. Cryoablation of small peripheral renal masses: a retrospective analysis. Urology 68 Suppl 1A (2006) 14-18
19. Lawatsch E.J., Langenstroer P., Byrd G.F., et al. Intermediate results of laparoscopic cryoablation in 59 patients at the Medical College of Wisconsin. J Urol 175 (2006) 1225-1229
20. Cestari A., Sangalli M., Buffi N., et al. Laparoscopic renal cryoablation (LRC) of small renal masses: lessons learned from 104 cases in a 7-year experience. Eur Urol Suppl 7 3 (2008) 192
21. Aron M., Kamoi K., Haber G.-P., et al. Laparoscopic renal cryoablation: long-term oncologic outcomes with minimum 5-year follow-up. J Urol 179 4 Suppl (2008) [abstract No. 596]
22. Gill I.S., Remer E.M., Hasan W.A., et al. Renal cryoablation: outcome at 3 years. J Urol 173 (2005) 1903-1907
23. Allaf M.E., Bhayani S.B., Rogers C., et al. Laparoscopic partial nephrectomy: evaluation of long-term oncologic outcome. J Urol 172 (2004) 871-873
24. Desai M.M., Aron M., and Gill I.S. Laparoscopic partial nephrectomy versus laparoscopic cryoablation for the small renal tumor. Urology 66 (2005) 23-28
25. Hruby G., Reisiger K., Venkatesh R., et al. Comparison of laparoscopic partial nephrectomy and laparoscopic cryoablation for renal hilar tumors. Urology 67 (2006) 50-54
26. Gupta A., Allaf M.E., Kavoussi L.R., et al. Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation: initial clinical experience. J Urol 175 (2006) 447-453
27. Atwell T.D., Farrell M.A., Leibovich B.C., et al. Percutaneous renal cryoablation: experience treating 115 tumors. J Urol 179 (2008) 2136-2141
28. Bassignani M.J., Moore Y., Watson L., et al. Pilot experience with real-time ultrasound guided percutaneous renal mass cryoablation. J Urol 171 (2004) 1620-1623
29. Rehman J., Landman J., Lee D., et al. Needle-based ablation of renal parenchyma using microwave, cryoablation, impedance- and temperature-based monopolar and bipolar radiofrequency, and liquid and gel chemoablation: laboratory studies and review of the literature. J Endourol 18 (2004) 83-104
30. Silverman S.G., Tuncali K., Van Sonnenberg E., et al. Renal tumors: MR imaging-guided percutaneous cryotherapy-initial experience in 23 patients. Radiology 236 (2005) 716-724
31. Sewell P., and Shingleton W. Five-year treatment success and survival of patients treated with percutaneous IMRI guided and monitored renal cell carcinoma cryoablation. BJU Int 94 (2004) 106 [abstract MP-1609]
32. Lehman D.S., Hruby G.W., Phillips C.K., et al. Laparoscopic renal cryoablation: efficacy and complications for larger renal masses. J Endourol 22 (2008) 1123-1127
33. Johnson D.B., Solomon S.B., Su L.M., et al. Defining the complications of cryoablation and radiofrequency ablation of small renal tumors: a multi-institutional review. J Urol 172 (2004) 874-877
34. Carvalhal E.F., Gill I.S., Meraney A.M., et al. Laparoscopic renal cryoablation: impact on renal function and blood pressure. Urology 58 (2001) 357-361
35. Finley D.S., Beck S., Box G., et al. Percutaneous and laparoscopic cryoablation of small renal masses. J Urol 180 (2008) 492-498
36. Cosman E.R., Nashold B.S., and Ovelman-Levitt J. Theoretical aspects of radiofrequency lesions in the dorsal root entry zone. Neurosurgery 15 (1984) 945-950
37. Corwin T.S., Lindberg G., Traxer O., et al. Laparoscopic radiofrequency thermal ablation of renal tissue with and without hilar occlusion. J Urol 166 (2001) 281-284
38. Gill I.S., Hsu T.H., Fox R.L., et al. Laparoscopic and percutaneous radiofrequency ablation of the kidney: acute and chronic porcine study. Urology 56 (2000) 197-200
39. Hoey M.F., Mulier P.M., Leveillee R.J., et al. Transurethral prostate ablation with saline electrode allows controlled production of larger lesions than conventional methods. J Endourol 11 (1997) 279-284
40. Renshaw A. The natural history of incidentally detected small renal masses. Cancer 101 (2004) 650-652
41. Merkle E.M., Shonk J.R., Duerk J.L., et al. MR-guided RF thermal ablation of the kidney in a porcine model. Am J Roentgenol 173 (1999) 645-651
42. Jacomides L., Ogan K., Watumall L., et al. Laparoscopic application of radiofrequency energy enables in situ renal tumor ablation and partial nephrectomy. J Urol 169 (2003) 49-53
43. Matsumoto E.D., Johnson D.B., Ogan K., et al. Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors. Urology 65 (2005) 877-881
44. Gervais D.A., McGovern F.J., Arellano R.S., et al. Radiofrequency ablation of renal cell carcinoma: part 1. Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 185 (2005) 64-71
45. Gervais D.A., Arellano R.S., McGovern F.J., et al. Radiofrequency ablation of renal cell carcinoma: part 2. Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol 185 (2005) 72-80
46. Stern J.M., Svatek R., Park S., et al. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumors. BJU Int 100 (2007) 287-290
47. Levinson A.W., Agarwal D., Sroka M., et al. Long-term oncologic and overall outcomes of radiofrequency ablation in high-risk patients with solitary renal masses. J Urol 179 Suppl 4 (2008) 330
48. Lucas S.M., Stern J.M., Adibi M., et al. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 179 (2008) 75-80
49. Traver M.A., Werle D.M., Clark P.E., et al. Oncological efficacy and factors influencing the success of computerized tomography (CT)-guided percutaneous radiofrequency ablation (RFA) on renal neoplasms. J Urol 175 Suppl (2006) 360
50. Weiser A.Z., Raj G., O'Connel M., et al. Complications after percutaneous radiofrequency ablation of renal tumors. Urology 66 (2005) 1176-1180
51. Weight C.J., Kaouk J.H., Hegarty N.J., et al. Correlation of radiographic imaging and histopathology following cryoablation and radiofrequency ablation for renal tumors. J Urol 179 (2008) 1277-1281
52. Marcovich R., Aldana J.P., Morgenstern N., et al. Optimal lesion assessment following acute radio frequency ablation of porcine kidney: cellular viability or histopathology?. J Urol 170 (2003) 1370-1374
53. Neumann R.A., Knobler R.M., Pieczkowski F., et al. Enzyme histochemical analysis of cell viability after argon laser-induced coagulation necrosis of the skin. J Am Acad Dermatol 25 (1991) 991-998
54. Michaels M.J., Rhee H.K., Mourtzinos A.P., et al. Incomplete renal tumor destruction using radio frequency interstitial ablation. J Urol 168 (2002) 2406-2410
55. Matlaga B.R., Zagoria R.J., Woodruff R.D., et al. Phase II trial of radio frequency ablation of renal cancer: evaluation of the kill zone. J Urol 168 (2002) 2401-2405
56. Stern J., Raman J.D., and Cadeddu J.A. Absence of viable carcinoma in biopsies performed greater than 1-year following radiofrequency ablation of renal cortical tumors. J Urol 179 4 Suppl (2008) 413
57. Ankem M.K., and Nakada S.Y. Needle ablative nephron sparing surgery. BJU Int 95 Suppl 2 (2005) 46-51
58. Liang P., Wang Y., Zhang D., et al. Ultrasound guided percutaneous microwave ablation for small renal cancer: initial experience. J Urol 180 (2008) 844-848
59. Marberger M., Schatzl G., Kranston D., et al. Extracorporeal ablation of renal tumors with high intensity focused ultrasound. BJU Int 95 Suppl 2 (2005) 52-55
60. Hacker A., Michel M.S., Marlinghaus E., et al. Extracorporeally induced ablation of renal tissue by high-intensity focused ultrasound. BJU Int 97 (2006) 779-785
61. Ponsky L.E., Crownover R.L., Rosen M.J., et al. Initial evaluation of CyberKnife technology for extracorporeal renal tissue ablation. Urology 61 3 (2003) 498-501
62. Ponsky L.E., Mahadevan A., Gill I.S., et al. Renal radiosurgery: initial clinical experience with histological evaluation. Surg Innov 14 4 (2007) 265-269
63. Hong YM, Shanmugham L, La Rosa S, et al. CyberKnife radiosurgical ablation of primary renal tumors. Personal correspondence. Presented at World Congress of Endourology, November 30-December 3, 2008; Shanghai, China.
64. Bentzen S.M., and Ritter M.A. The α/β ratio for prostate cancer: what is it, really?. Radiother Oncol 76 (2005) 1-3
65. King C.R., and Fowler J.F. A simple analytic derivation suggests that prostate cancer α/β ratio is low. Int J Radiat Oncol Biol Phys 51 (2001) 213-214
66. King C.R., Lehmann J., Adler J.R., et al. CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility. Technol Cancer Res Treat 2 (2003) 25-29
67. Madsen B.L., His R.A., Pham H.T., et al. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. Int J Radiat Oncol Biol Phys 67 (2007) 1099-1105
68. Cooper I.S., and Lee A.S. Cryostatic congelation: a system for producing a limited, controlled region of cooling or freezing of biological tissue. J Nerv Ment Dis 133 (1961) 259-263
69. Gage A.A., and Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 37 (1998) 171-186
70. Gonder M.J., Soanes W.A., and Shulman S. Cryosurgical treatment of the prostate. Invest Urol 3 (1966) 372-378
71. Onik G.M., Cohen J.K., Reyes G.D., et al. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 72 (1993) 1291-1299
72. Saliken J.C., Donnelly B.J., and Rewcastle J.C. The evolution and state of modern technology for prostate cryosurgery. Urology 60 (2002) 26-33
73. Katz A.E., and Rewcastle J.C. The current and potential role of cryoablation as a primary therapy for localized prostate cancer. Curr Oncol Rep 5 (2003) 231-238
74. Shinohara K. Prostate cancer cryotherapy. Urol Clin North Am 30 (2003) 725-736
75. Long J.P., Bahn D., Lee F., et al. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology 57 3 (2001) 518-523
76. Bahn D.K., Lee F., Badalament R., et al. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 60 (2002) 3-11
77. Agarwal P.K., Sadetsky N., Konety B.R., et al. Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care and outcomes. Cancer 112 (2008) 307-314
78. Crook J.M., Perry G.A., Robertson S., et al. Routine biopsies following radiotherapy for prostate cancer: results for 226 patients. Urology 45 (1995) 624-632
79. Babaian R.J., Donnelly B., Bahn D., et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol 180 (2008) 1993-2004
80. Bahn D.K., Lee F., Silverman P., et al. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer 2 (2003) 111-114
81. Chin J.L., Pautler S.E., Mouraviev V., et al. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol 165 (2001) 1937-1941
82. Hamoui O., Wiegand L., Pisters L.L., et al. Ten-year treatment outcomes of salvage cryotherapy for locally recurrent prostate cancer. J Urol 179 Suppl 4 (2008) 253
83. Donnelly B.J., Saliken J.C., Ernst D.S., et al. Prospective trial of cryosurgical ablation of the prostate: five year results. Urology 60 (2002) 645-649
84. Ellis D.S. Cryosurgery as a primary treatment for localized prostate cancer: a community hospital experience. Urology 60 (2002) 34-39
85. Han K.-R., Cohen J.K., Miller R.J., et al. Treatment of organ-confined prostate cancer with third generation cryosurgery: preliminary multi-center experience. J Urol 170 (2003) 1126-1130
86. Robinson J.W., Donnelly B.J., Saliken J.C., et al. Quality of life and sexuality of men with prostate cancer 3 years after cryosurgery. Urology 60 2 Suppl 1 (2002) 12-18
87. Ellis D.S., Manny Jr. T.B., and Rewcastle J.C. Cryoablation as a primary treatment for localized prostate cancer followed by penile rehabilitation. Urology 69 (2007) 306-310
88. Pisters L.L., Rewcastle J.C., Donnelly B.J., et al. Salvage prostate cryoablation: initial results from the cryo on-line data registry. J Urol 180 (2008) 559-565
89. Madersbacher S., Padevilla M., Vingers L., et al. Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res 55 (1995) 3346-3351
90. Chapelon J.Y., Ribault M., Vernier F., et al. Treatment of localized prostate cancer with transrectal high intensity focused ultrasound. Eur J Ultrasound 9 (1999) 31-38
91. Thuroff S., Chaussy C., Vallancien G., et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European Multicentric Study. J Endourol 17 (2003) 673-677
92. Beerlage H.P., Thuroff S., Debruyne F.M., et al. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. Urology 54 (1999) 273-277
93. Blana A., Walter B., Rogenhofer S., et al. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology 63 (2004) 297-300
94. Uchida T., Nitta M., Hongo S., et al. High-intensity focused ultrasound for the treatment in 503 patients with localized prostate cancer. Urology 70 3 Suppl 1 (2007) 2
95. Gelet A., Chapelon J.Y., Bouvier R., et al. Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome. Eur Urol 40 (2001) 124-129
96. Vallancien G., Prapotnich D., Cathelineau X., et al. Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study. Urology 171 (2004) 2265-2267